Cygnus Biosciences (Beijing) Co., Ltd.
PrivateLast Round
VC Round
Oct 21, 2025
Total Funding Raised
$70.71M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cygnus Biosciences (Beijing) Co., Ltd. is a biotechnology company that develops, produces, and markets gene sequencing instruments, reagents, and genomic solutions for research, medical diagnosis, and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Precision Medicine, Computing Hardware
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cygnus Biosciences (Beijing) Co., Ltd. Comparables
Compare Cygnus Biosciences (Beijing) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GeneMind Biosciences Co., Ltd. | 85% | |
| Qitan Tech | 83% | |
| Axbio | 80% |
Cygnus Biosciences (Beijing) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 21, 2025 | ||||
| Series C Extension | Mar 20, 2023 | ||||
| Series C | Jun 11, 2020 | ||||
| Series B Extension | Jun 12, 2018 | ||||
| Series B | Nov 14, 2017 | ||||
Series A | Nov 1, 2015 |
Cygnus Biosciences (Beijing) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing E-Town International Investment & Development Co., Ltd. | Series C Extension, VC Round |
| Qiaojing Capital | Series B Extension |
| Source Code Capital | Series C Extension |
| Hotung Investment Holdings Limited | Series C Extension |
| 清控银杏创业投资管理（北京）有限公司 | Series B Extension |
| Zhongguancun Development Group | Series B |
| Founder Hesheng Investment Co., Ltd. | Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 21, 2025
Led by Beijing E-Town International Investment & Development Co., Ltd.
- Nov 1, 2015
$7.85M round closed
Cygnus Biosciences (Beijing) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cygnus Biosciences (Beijing) Co., Ltd.'s valuation, stock price, and market status.
Is Cygnus Biosciences (Beijing) Co., Ltd. a public or private company?
Cygnus Biosciences (Beijing) Co., Ltd. is a private company.
What is the current stock price of Cygnus Biosciences (Beijing) Co., Ltd.?
Cygnus Biosciences (Beijing) Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Cygnus Biosciences (Beijing) Co., Ltd. worth (valuation)?
Valuation information for Cygnus Biosciences (Beijing) Co., Ltd. is not publicly available.
Can I buy Cygnus Biosciences (Beijing) Co., Ltd. stock?
Cygnus Biosciences (Beijing) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cygnus Biosciences (Beijing) Co., Ltd.'s last funding round?
Cygnus Biosciences (Beijing) Co., Ltd.'s most recent funding round was Series C Extension on March 20, 2023.
Who are the main investors in Cygnus Biosciences (Beijing) Co., Ltd.?
Key investors in Cygnus Biosciences (Beijing) Co., Ltd. include Source Code Capital, THG Ventures, Zhongguancun Development Group.
Will Cygnus Biosciences (Beijing) Co., Ltd. IPO soon?
No public IPO plans have been announced for Cygnus Biosciences (Beijing) Co., Ltd..
How can I track Cygnus Biosciences (Beijing) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cygnus Biosciences (Beijing) Co., Ltd.'s secondary market activity and sign up for updates.